What it's for (Indications)
- Iron Hydroxide Polymaltose Complex (IPC) with Folic Acid is primarily indicated for the treatment and prophylaxis of combined iron deficiency anemia (IDA) and folate deficiency, particularly in populations with increased physiological demands or impaired absorption.
- This includes pregnant and lactating women, adolescents experiencing rapid growth, individuals with chronic blood loss (e.
- g.
- , menorrhagia, gastrointestinal bleeding), patients with malabsorption syndromes, and those undergoing dialysis.
- It is also prescribed for individuals with inadequate dietary intake of iron and folic acid or increased metabolic demands during illness or recovery.
- Accurate diagnosis of underlying anemia type is crucial before initiation of therapy to ensure appropriate treatment and avoid masking other hematological conditions.
- The combination aims to replete iron stores and ensure adequate folate levels, both essential for erythropoiesis and overall metabolic function.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of Iron Hydroxide Polymaltose Complex with Folic Acid should be individualized based on the severity of the iron and folate deficiency, the patient's age, and their response to treatment. For adult patients and adolescents, a common regimen involves administering one tablet (typically containing 100 mg of elemental iron as IPC and 0.35-0.5 mg of folic acid) once daily, preferably during or immediately after meals to minimize potential gastrointestinal discomfort. In severe cases of deficiency, the dosage may be adjusted by a healthcare professional. Treatment duration typically extends for several months after the normalization of hemoglobin levels to ensure the repletion of body iron stores, which can take an additional 1 to 3 months. It is imperative not to exceed the prescribed dose, and adherence to the full course of therapy is crucial for achieving optimal therapeutic outcomes and preventing relapse. |
Safety & Warnings
Common Side Effects
- While generally well-tolerated, particularly due to the favorable gastrointestinal profile of Iron Hydroxide Polymaltose Complex compared to traditional iron salts, some side effects may occur.
- Common gastrointestinal disturbances include nausea, constipation, diarrhea, abdominal pain or discomfort, and a harmless black discoloration of the stools, which is typical for oral iron supplementation.
- Less frequently, patients may experience vomiting or dyspepsia.
- Allergic reactions, though rare, can manifest as skin rash, pruritus, or anaphylaxis, primarily attributable to folic acid or other excipients.
- It is important for patients to report any persistent or severe side effects to their healthcare provider.
- The incidence of severe side effects is generally low, making this combination a preferred choice for many patients requiring iron and folate supplementation.
Serious Warnings
- Black Box Warning: Serious Warnings: **Accidental Overdose of Iron-Containing Products:** Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. Symptoms of iron overdose can be severe and life-threatening, including gastrointestinal irritation, vomiting, diarrhea, abdominal pain, and in severe cases, metabolic acidosis, cardiovascular collapse, and liver necrosis. **Masking of Vitamin B12 Deficiency:** Folic acid, even in small doses, may obscure the diagnosis of pernicious anemia (Vitamin B12 deficiency) by improving the megaloblastic anemia while allowing the potentially irreversible neurological damage to progress. This can lead to severe and permanent neurological impairment if the underlying Vitamin B12 deficiency is not identified and treated promptly. Therefore, before initiating therapy with Iron Hydroxide Polymaltose Complex with Folic Acid, it is crucial to rule out Vitamin B12 deficiency, especially in elderly patients or individuals with risk factors for malabsorption. Appropriate diagnostic testing, including serum Vitamin B12 levels, should be performed to ensure accurate diagnosis and prevent adverse neurological outcomes.
- Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age.
- This medication must be kept out of reach of children.
- It is essential to accurately diagnose the type of anemia before initiating treatment; this preparation is specifically for iron and folate deficiency.
- Folic acid, when administered alone, may mask the hematological manifestations of pernicious anemia (Vitamin B12 deficiency) while allowing the neurological complications to progress, which can be irreversible.
- Therefore, patients with suspected pernicious anemia should have their Vitamin B12 levels assessed before or concurrently with folic acid supplementation.
- Caution is advised in patients with active peptic ulcer, inflammatory bowel disease, or severe gastrointestinal disturbances.
- Patients with existing iron overload conditions, such as hemochromatosis or hemosiderosis, should not take this medication.
- Additionally, certain medications can interact with iron and folic acid, affecting absorption or efficacy, including tetracycline antibiotics, antacids, fluoroquinolones, levodopa, and thyroid hormones.
- Consultation with a healthcare professional is crucial to manage potential drug interactions and ensure safe use.
How it Works (Mechanism of Action)
Iron Hydroxide Polymaltose Complex (IPC) with Folic Acid combines two essential hematinic agents. The Iron Hydroxide Polymaltose Complex is a non-ionic, water-soluble macromolecular complex that delivers iron in a controlled manner. Unlike traditional iron salts, IPC’s iron is in a ferric state and is surrounded by a polymaltose ligand, which prevents the formation of free iron ions in the gastrointestinal tract. This complex structure minimizes irritation to the gastric mucosa, reduces oxidative stress, and leads to better tolerability. Iron, an indispensable component of hemoglobin, myoglobin, and various enzymes, is vital for oxygen transport, cellular respiration, and numerous metabolic processes. Once absorbed, it is transported to the bone marrow for erythropoiesis and stored as ferritin. Folic acid (Vitamin B9) is a precursor to tetrahydrofolic acid, a coenzyme critical for single-carbon metabolism, including DNA and RNA synthesis. It is essential for the maturation of red blood cells in the bone marrow and plays a crucial role in cell division and growth. The combination effectively treats both microcytic, hypochromic anemia (due to iron deficiency) and megaloblastic anemia (due to folate deficiency), ensuring adequate substrates for healthy red blood cell production.